TickerFactsScreenerDevelopers

DiaMedica Therapeutics Inc. (DMAC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$4.52M2018: -$6.76M2019: -$11.59M2020: -$12.70M2021: -$13.65M2022: -$14.00M2023: -$21.27M2024: -$26.68M2025: -$34.40M-$34.40M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$34.40M-28.9%
2024-$26.68M-25.5%
2023-$21.27M-51.9%
2022-$14.00M-2.6%
2021-$13.65M-7.5%
2020-$12.70M-9.5%
2019-$11.59M-71.5%
2018-$6.76M-49.6%
2017-$4.52M—